RightFit Trial Directory

Colorectal Cancer clinical trials in Houston, TX

87 recruiting colorectal cancer studies with a site in Houston, TX.

All trials in Houston, TX · All Colorectal Cancer trials

RecruitingPhase 3NCT07525206

A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer

Sponsor: AbbVie

Abilene, TX · Houston, TX · +16 more sites

RecruitingPhase 1 / Phase 2NCT07020221

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Sponsor: Verastem, Inc.

Houston, TX · +12 more sites

RecruitingPhase 1 / Phase 2NCT05786924

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Sponsor: Institut de Recherches Internationales Servier

Houston, TX · San Antonio, TX · +19 more sites

RecruitingPhase 2NCT07023289

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Sponsor: AbbVie

Austin, TX · Fort Worth, TX · Grapevine, TX · +19 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Abilene, TX · Amarillo, TX · Beaumont, TX · +251 more sites

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Houston, TX · San Antonio, TX · +29 more sites

RecruitingPhase 1NCT06400472

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

Sponsor: Eli Lilly and Company

Houston, TX · +10 more sites

RecruitingPhase 1 / Phase 2NCT06710756

Lead-212 PSV359 Therapy for Patients With Solid Tumors

Sponsor: Perspective Therapeutics

Dallas, TX · Houston, TX · +14 more sites

RecruitingPhase 2NCT06887218

5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal Cancer

Sponsor: The Methodist Hospital Research Institute

Houston, TX

RecruitingPhase 1NCT07114601

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Sponsor: Eli Lilly and Company

Dallas, TX · Houston, TX · +14 more sites

RecruitingPhase 1NCT04429542

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Sponsor: Bicara Therapeutics

Houston, TX · +14 more sites

RecruitingPhase 1 / Phase 2NCT06428409

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Sponsor: Merck Sharp & Dohme LLC

Houston, TX · +12 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

Dallas, TX · Fort Worth, TX · +109 more sites

RecruitingPhase 1NCT07416552

A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)

Sponsor: Hoffmann-La Roche

Houston, TX · +4 more sites

RecruitingPhase 1 / Phase 2NCT07411599

Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) Knock Out (KO) Therapy For Colorectal Cancer-Related Peritoneal Carcinomatosis: A Phase 1/2 Trial ("Chip-CRC Trial")

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1NCT06270706

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Sponsor: Pliant Therapeutics, Inc.

Austin, TX · Fort Worth, TX · Houston, TX · +13 more sites

RecruitingPhase 2NCT06760819

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Sponsor: Bayer

Houston, TX · +10 more sites

RecruitingPhase 1 / Phase 2NCT07189871

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Sponsor: Radiopharm Theranostics, Ltd

Houston, TX · +4 more sites

RecruitingPhase 1NCT07085091

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Sponsor: ALX Oncology Inc.

Houston, TX · +11 more sites

RecruitingPhase 1NCT05877599

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Sponsor: AstraZeneca

Houston, TX · Round Rock, TX · +18 more sites

RecruitingPhase 2NCT07551596

Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial

Sponsor: National Cancer Institute (NCI)

Houston, TX · +1 more sites

RecruitingPhase 1 / Phase 2NCT05482893

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

Sponsor: Phanes Therapeutics

Houston, TX · +10 more sites

RecruitingPhase 1NCT06004245

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

Sponsor: Vividion Therapeutics, Inc.

Houston, TX · San Antonio, TX · +14 more sites

RecruitingPhase 1NCT06218914

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Sponsor: AstraZeneca

Dallas, TX · Galveston, TX · Houston, TX · +15 more sites

RecruitingPhase 2NCT06369259

Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in Patients With Unresectable, Anti-EGFR-Refractory Advanced Colorectal Cancer

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 2NCT05489211

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Sponsor: AstraZeneca

Houston, TX · +17 more sites

RecruitingPhase 1 / Phase 2NCT06445062

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Sponsor: Revolution Medicines, Inc.

Houston, TX · Irving, TX · +29 more sites

RecruitingPhase 1 / Phase 2NCT07262619

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

Sponsor: Eikon Therapeutics

Fort Worth, TX · Houston, TX · +8 more sites

RecruitingPhase 1 / Phase 2NCT07488676

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Sponsor: Astellas Pharma Global Development, Inc.

Austin, TX · Houston, TX · Irving, TX · +15 more sites

RecruitingPhase 1 / Phase 2NCT07629960

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

Sponsor: Blueprint Medicines Corporation

Houston, TX · +9 more sites

RecruitingPhase 1 / Phase 2NCT07693751

A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

Sponsor: SOTIO Biotech a.s.

Houston, TX · +1 more sites

RecruitingPhase 1NCT07020117

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Sponsor: Aktis Oncology, Inc.

Houston, TX · +13 more sites

RecruitingPhase 1NCT07217171

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Sponsor: EvolveImmune United, Inc

Houston, TX · +15 more sites

RecruitingPhase 1NCT06440005

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Sponsor: Angiex, Inc.

Houston, TX · San Antonio, TX · +5 more sites

RecruitingPhase 1NCT07216105

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Sponsor: Fate Therapeutics

Houston, TX · +4 more sites

RecruitingPhase not listedNCT02107105

Evaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal Cancer

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 2NCT07071961

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 1 / Phase 2NCT04851119

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Sponsor: Children's Oncology Group

Houston, TX · +20 more sites

RecruitingPhase 1NCT06586515

MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors

Sponsor: Eli Lilly and Company

Houston, TX · San Antonio, TX · +23 more sites

RecruitingPhase 2NCT06792695

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Sponsor: AstraZeneca

Houston, TX · +13 more sites

RecruitingPhase 1 / Phase 2NCT04895709

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Sponsor: Bristol-Myers Squibb

Houston, TX · +10 more sites

RecruitingPhase 1NCT07066657

A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

Sponsor: ArriVent BioPharma, Inc.

Houston, TX · Irving, TX · +8 more sites

RecruitingPhase 1 / Phase 2NCT05592626

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Sponsor: Marengo Therapeutics, Inc.

Houston, TX · San Antonio, TX · +11 more sites

RecruitingPhase 1NCT06242470

A Study of MGC026 in Participants With Advanced Solid Tumors

Sponsor: MacroGenics

Houston, TX · +5 more sites

RecruitingPhase 1 / Phase 2NCT06751329

A Study of DM002 in Patients With Advanced Solid Tumors

Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.

Houston, TX · +3 more sites

RecruitingPhase not listedNCT06880055

Shield Post-Approval Study Protocol

Sponsor: Guardant Health, Inc.

Austin, TX · Houston, TX · +66 more sites

RecruitingNot applicableNCT05826743

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

Sponsor: JSR Medical Co., Ltd.

Houston, TX · +2 more sites

RecruitingPhase 1NCT06910657

IDOV-Immune for Advanced Solid Tumors

Sponsor: ViroMissile, Inc.

Houston, TX · San Antonio, TX · +1 more sites

RecruitingPhase 1 / Phase 2NCT04657068

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Sponsor: Artios Pharma Ltd

Austin, TX · Dallas, TX · +38 more sites

RecruitingPhase 1 / Phase 2NCT03526835

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

Sponsor: Merus B.V.

Dallas, TX · Houston, TX · Tyler, TX · +28 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.